The purpose of this study is to demonstrate that virologically controlled HIV-infected
individuals can successfully switch from a standard-of-care regimen dosed twice-daily or more
frequently to a simpler once-daily (QD) regimen while maintaining virologic control, as
evaluated by the proportion of subjects who continue to have plasma HIV-1...Read More
levels <50
copies/mL after switching to a QD regimen.Read Less